Cisatracurium APOTEX cisatracurium (as besilate) 5 mg / 2.5 mL solution for injection ampoule

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

cisatracurium besilate, Quantity: 2.68 mg/mL (Equivalent: cisatracurium, Qty 2 mg/mL)

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

cisatracurium besilate

Għamla farmaċewtika:

Injection, solution

Kompożizzjoni:

Excipient Ingredients: water for injections; benzenesulfonic acid

Rotta amministrattiva:

Intravenous, Intravenous Infusion

Unitajiet fil-pakkett:

5

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. It is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Sommarju tal-prodott:

Visual Identification: Colourless, transparent solution; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2016-04-12